Since Nutlin3a (20 mg/kg); an MDM2 inhibitor, had been shown to ameliorated kidney injury by ischemia‐reperfusion 12 or crescentic glomerulonephritis,13 we anticipated that MDM2 inhibitors would also have some protective effects on cisplatin nephropathy. Here, MDM2 is linked to crescentic glomerulonephritis.